| Ticker Details |
|
Sana Biotechnology, Inc.
|
| IPO Date: |
February 1, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.07B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.34 | 4.28%
|
| Avg Daily Range (30 D): |
$0.14 | 3.21%
|
| Avg Daily Range (90 D): |
$0.21 | 4.78%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.91M |
| Avg Daily Volume (30 D): |
2M |
| Avg Daily Volume (90 D): |
3.85M |
| Trade Size |
| Avg Trade Size (Sh.): |
143 |
| Avg Trade Size (Sh.) (30 D): |
131 |
| Avg Trade Size (Sh.) (90 D): |
174 |
| Institutional Trades |
| Total Institutional Trades: |
1,457 |
| Avg Institutional Trade: |
$1.82M |
| Avg Institutional Trade (30 D): |
$.92M |
| Avg Institutional Trade (90 D): |
$1.27M |
| Avg Institutional Trade Volume: |
.25M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.94M |
| Avg Closing Trade (30 D): |
$.95M |
| Avg Closing Trade (90 D): |
$1.39M |
| Avg Closing Volume: |
268.89K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.96
|
$-.16
|
$-.39
|
|
Diluted EPS
|
$-.96
|
$-.16
|
$-.39
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-234.41M
|
$-42.15M
|
$-93.8M
|
|
Operating Income / Loss
|
$-239.99M
|
$-43.52M
|
$-94.98M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-23.28M
|
$32.09M
|
$-24.86M
|
|
PE Ratio
|
|
|
|
|
|
|